Evaluating drug-coated balloons for new coronary artery lesions

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This international multicenter registry focuses on the use of drug-coated balloons (DCBs) for treating de novo coronary lesions. The study aims to assess the safety and efficacy of DCBs compared to traditional methods like plain old balloon angioplasty and drug-eluting stents. By analyzing clinical and angiographic outcomes, the research seeks to provide insights into the long-term benefits of DCBs in this patient population. The study is particularly relevant given the limited data on DCB-only approaches for new coronary lesions.

Why it matters

Who can join: the full rules

Inclusion Criteria:

\- de novo coronary artery disease

Exclusion Criteria:

* unstable hemodynamics at presentation
* life expectancy \<1 year

Where it's running

• Ulsan Medical Center
  Ulsan, South Korea Recruiting

Study contacts

• Principal investigator: Soo-Jin Kim — IRB
• Study coordinator: Eun-Seok Shin
• Email: sesim1989@gmail.com

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Impact of Procedural Factors on Drug-Coated Balloon Outcomes in Coronary Artery Disease

  This registry tests whether delivery time and inflation duration of drug-coated balloons affect outcomes in adults undergoing PCI for new coronary lesions.

  Recruiting at 7 sites Nanjing First Hospital, Nanjing Medical University · Chuzhou, Anhui and 6 other locations · NCT07764094

• Crystalline sirolimus-coated balloon for treating coronary artery disease

  This tests whether a crystalline sirolimus-coated balloon is safe and effective for adults having percutaneous coronary intervention for coronary artery blockages or in-stent restenosis.

  Recruiting Fundación Interhospitalaria para la Investigación Cardiovascular FIC · Vigo, Pontevedra · NCT07444957

• Long Passeo-18 Lux balloon for leg artery blockages

  A single-arm trial tests a long paclitaxel-releasing balloon to treat new or recurring leg artery blockages in adults.

  Recruiting at 4 sites KANDO Research · Aalst and 3 other locations · NCT07385573

• Outcomes after PCI using the Protégé paclitaxel drug-coated balloon.

  This registry will collect real-world data to see if the Protégé paclitaxel drug-coated balloon works well and is safe for adults having PCI for coronary artery disease or acute coronary syndrome.

  Recruiting Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · Amsterdam · NCT07231835

• Drug-coated balloon with bail-out bioresorbable scaffold versus scaffold alone for new coronary artery blockages

  This test sees if using a drug-coated balloon with bail-out bioresorbable scaffold works as well as using a bioresorbable scaffold alone for adults 18–68 getting PCI for new coronary artery blockages, including certain heart attacks and unstable angina.

  Recruiting Ceric Sàrl · Tallinn · NCT07038408

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.